An Efficacy and Safety Study of Bortezomib Re-treatment in Multiple Myeloma
Clinical trial NCT00431769 · COMPLETED
Trial details
- NCT number
- NCT00431769
- Sponsor
- Janssen-Cilag International NV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2009-02-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.